{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:30:38Z","timestamp":1792668638481,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222095"],"award-info":[{"award-number":["7222095"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-05959-7","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T06:02:51Z","timestamp":1724824971000},"page":"4839-4849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Virus-driven dysregulation of the BCR pathway: a potential mechanism for the high prevalence of HIV related B-cell lymphoma"],"prefix":"10.1007","volume":"103","author":[{"given":"Ying","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"issue":"7","key":"5959_CR1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.2020005469","volume":"139","author":"A Carbone","year":"2022","unstructured":"Carbone A, Vaccher E, Gloghini A (2022) Hematologic cancers in individuals infected by HIV. Blood 139(7):995\u20131012","journal-title":"Blood"},{"issue":"6","key":"5959_CR2","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S1470-2045(21)00137-6","volume":"22","author":"EY Chiao","year":"2021","unstructured":"Chiao EY, Coghill A, Kizub D, Fink V, Ndlovu N, Mazul A et al (2021) The effect of non-AIDS-defining cancers on people living with HIV. Lancet Oncol 22(6):e240\u2013e253","journal-title":"Lancet Oncol"},{"issue":"6","key":"5959_CR3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C de Martel","year":"2012","unstructured":"de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D et al (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13(6):607\u2013615","journal-title":"Lancet Oncol"},{"issue":"11","key":"5959_CR4","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","volume":"4","author":"RU Hern\u00e1ndez-Ram\u00edrez","year":"2017","unstructured":"Hern\u00e1ndez-Ram\u00edrez RU, Shiels MS, Dubrow R, Engels EA (2017) Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV 4(11):e495\u2013e504","journal-title":"Lancet HIV"},{"key":"5959_CR5","doi-asserted-by":"crossref","first-page":"102370","DOI":"10.1016\/j.eclinm.2023.102370","volume":"67","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhao J, Sun P, Cheng M, Xiong Y, Sun Z et al (2024) Estimates of the global burden of non-hodgkin lymphoma attributable to HIV: a population attributable modeling study. EClinicalMedicine 67:102370","journal-title":"EClinicalMedicine"},{"issue":"3","key":"5959_CR6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/1055-9965.EPI-20-1045","volume":"30","author":"I Poizot-Martin","year":"2021","unstructured":"Poizot-Martin I, Lions C, Allavena C, Huleux T, Bani-Sadr F, Cheret A et al (2021) Spectrum and Incidence trends of AIDS- and Non-AIDS-Defining cancers between 2010 and 2015 in the French Dat\u2019AIDS Cohort. Cancer Epidemiol Biomarkers Prev 30(3):554\u2013563","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1\u20133","key":"5959_CR7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12026-010-8168-8","volume":"48","author":"M Epeldegui","year":"2010","unstructured":"Epeldegui M, Vendrame E, Mart\u00ednez-Maza O (2010) HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma. Immunol Res 48(1\u20133):72\u201383","journal-title":"Immunol Res"},{"issue":"4","key":"5959_CR8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/hupa.2002.124723","volume":"33","author":"A Carbone","year":"2002","unstructured":"Carbone A (2002) AIDS-related non-hodgkin\u2019s lymphomas: from pathology and molecular pathogenesis to treatment. Hum Pathol 33(4):392\u2013404","journal-title":"Hum Pathol"},{"issue":"11","key":"5959_CR9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2015-11-681411","volume":"127","author":"R Dolcetti","year":"2016","unstructured":"Dolcetti R, Gloghini A, Caruso A, Carbone A (2016) A lymphomagenic role for HIV beyond immune suppression? Blood 127(11):1403\u20131409","journal-title":"Blood"},{"issue":"52","key":"5959_CR10","doi-asserted-by":"crossref","first-page":"E7230","DOI":"10.1073\/pnas.1507459112","volume":"112","author":"N Knies","year":"2015","unstructured":"Knies N, Alankus B, Weilemann A, Tzankov A, Brunner K, Ruff T et al (2015) Lymphomagenic CARD11\/BCL10\/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-\u03baB and JNK activation. Proc Natl Acad Sci U S A 112(52):E7230\u20137238","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7277","key":"5959_CR11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","volume":"463","author":"RE Davis","year":"2010","unstructured":"Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB et al (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463(7277):88\u201392","journal-title":"Nature"},{"issue":"12","key":"5959_CR12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nri955","volume":"2","author":"H Niiro","year":"2002","unstructured":"Niiro H, Clark EA (2002) Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2(12):945\u2013956","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 7","key":"5959_CR13","doi-asserted-by":"crossref","first-page":"e25831","DOI":"10.1002\/jia2.25831","volume":"24","author":"WB Williams","year":"2021","unstructured":"Williams WB, Wiehe K, Saunders KO, Haynes BF (2021) Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies. J Int AIDS Soc 24(Suppl 7):e25831","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"5959_CR14","doi-asserted-by":"crossref","first-page":"15678","DOI":"10.1002\/jcp.28219","volume":"234","author":"FB Sall","year":"2019","unstructured":"Sall FB, El Amine R, Markozashvili D, Tsfasman T, Oksenhendler E, Lipinski M et al (2019) HIV-1 Tat protein induces aberrant activation of AICDA in human B-lymphocytes from peripheral blood. J Cell Physiol 234(9):15678\u201315685","journal-title":"J Cell Physiol"},{"issue":"2","key":"5959_CR15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2353\/ajpath.2009.080451","volume":"175","author":"M El-Salem","year":"2009","unstructured":"El-Salem M, Raghunath PN, Marzec M, Liu X, Kasprzycka M, Robertson E et al (2009) Activation of mTORC1 signaling pathway in AIDS-related lymphomas. Am J Pathol 175(2):817\u2013824","journal-title":"Am J Pathol"},{"issue":"3","key":"5959_CR16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-3083.2012.02751.x","volume":"76","author":"N Almqvist","year":"2012","unstructured":"Almqvist N, M\u00e5rtensson IL (2012) The pre-B cell receptor; selecting for or against autoreactivity. Scand J Immunol 76(3):256\u2013262","journal-title":"Scand J Immunol"},{"issue":"5","key":"5959_CR17","first-page":"E458","volume":"112","author":"A Sun","year":"2015","unstructured":"Sun A, Novobrantseva TI, Coffre M, Hewitt SL, Jensen K, Skok JA et al (2015) VH replacement in primary immunoglobulin repertoire diversification. Proc Natl Acad Sci U S A 112(5):E458\u2013466","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"5959_CR18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nri.2017.19","volume":"17","author":"D Nemazee","year":"2017","unstructured":"Nemazee D (2017) Mechanisms of central tolerance for B cells. Nat Rev Immunol 17(5):281\u2013294","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"5959_CR19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","volume":"102","author":"M Muramatsu","year":"2000","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102(5):553\u2013563","journal-title":"Cell"},{"issue":"11","key":"5959_CR20","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood-2012-03-415380","volume":"120","author":"GD Victora","year":"2012","unstructured":"Victora GD, Dominguez-Sola D, Holmes AB, Deroubaix S, Dalla-Favera R, Nussenzweig MC (2012) Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood 120(11):2240\u20132248","journal-title":"Blood"},{"key":"5959_CR21","doi-asserted-by":"crossref","first-page":"683597","DOI":"10.3389\/fimmu.2021.683597","volume":"12","author":"N Mossadegh-Keller","year":"2021","unstructured":"Mossadegh-Keller N, Brisou G, Beyou A, Nadel B, Roulland S (2021) Human B Lymphomas Reveal their secrets through genetic mouse models. Front Immunol 12:683597","journal-title":"Front Immunol"},{"issue":"46","key":"5959_CR22","doi-asserted-by":"crossref","first-page":"13168","DOI":"10.1073\/pnas.1615258113","volume":"113","author":"VA Carroll","year":"2016","unstructured":"Carroll VA, Lafferty MK, Marchionni L, Bryant JL, Gallo RC, Garzino-Demo A (2016) Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice. Proc Natl Acad Sci U S A 113(46):13168\u201313173","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"5959_CR23","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1097\/QAD.0000000000002653","volume":"34","author":"V Shponka","year":"2020","unstructured":"Shponka V, Reveles CY, Alam S, Jaramillo M, Maguire A, Rimsza LM et al (2020) Frequent expression of activation-induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV. Aids 34(14):2025\u20132035","journal-title":"Aids"},{"issue":"4962","key":"5959_CR24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1126\/science.2360047","volume":"248","author":"MA Oettinger","year":"1990","unstructured":"Oettinger MA, Schatz DG, Gorka C, Baltimore D (1990) RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248(4962):1517\u20131523","journal-title":"Science"},{"issue":"4","key":"5959_CR25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri2941","volume":"11","author":"DG Schatz","year":"2011","unstructured":"Schatz DG, Ji Y (2011) Recombination centres and the orchestration of V(D)J recombination. Nat Rev Immunol 11(4):251\u2013263","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"5959_CR26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2011.02.007","volume":"34","author":"SD Fugmann","year":"2011","unstructured":"Fugmann SD (2011) RAG-2 unleashed: lymphocytes beware. Immunity 34(2):137\u2013139","journal-title":"Immunity"},{"issue":"11","key":"5959_CR27","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/leu.2017.106","volume":"31","author":"D Germini","year":"2017","unstructured":"Germini D, Tsfasman T, Klibi M, El-Amine R, Pichugin A, Iarovaia OV et al (2017) HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells. Leukemia 31(11):2515\u20132522","journal-title":"Leukemia"},{"key":"5959_CR28","doi-asserted-by":"crossref","first-page":"107515","DOI":"10.1016\/j.intimp.2021.107515","volume":"95","author":"NM Nilavar","year":"2021","unstructured":"Nilavar NM, Raghavan SC (2021) HIV integrase inhibitors that inhibit strand transfer interact with RAG1 and hamper its activities. Int Immunopharmacol 95:107515","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5959_CR29","doi-asserted-by":"crossref","first-page":"e2852","DOI":"10.1038\/cddis.2017.237","volume":"8","author":"M Nishana","year":"2017","unstructured":"Nishana M, Nilavar NM, Kumari R, Pandey M, Raghavan SC (2017) HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination. Cell Death Dis 8(6):e2852","journal-title":"Cell Death Dis"},{"key":"5959_CR30","doi-asserted-by":"crossref","first-page":"634383","DOI":"10.3389\/fonc.2021.634383","volume":"11","author":"P Oppezzo","year":"2021","unstructured":"Oppezzo P, Navarrete M, Chiorazzi N (2021) AID in chronic lymphocytic leukemia: induction and action during Disease Progression. Front Oncol 11:634383","journal-title":"Front Oncol"},{"issue":"7","key":"5959_CR31","doi-asserted-by":"crossref","first-page":"e11448","DOI":"10.1371\/journal.pone.0011448","volume":"5","author":"M Epeldegui","year":"2010","unstructured":"Epeldegui M, Thapa DR, De la Cruz J, Kitchen S, Zack JA, Mart\u00ednez-Maza O (2010) CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes. PLoS ONE 5(7):e11448","journal-title":"PLoS ONE"},{"issue":"5","key":"5959_CR32","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1128\/JVI.06259-11","volume":"86","author":"M Melchers","year":"2012","unstructured":"Melchers M, Bontjer I, Tong T, Chung NP, Klasse PJ, Eggink D et al (2012) Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses. J Virol 86(5):2488\u20132500","journal-title":"J Virol"},{"issue":"7","key":"5959_CR33","doi-asserted-by":"crossref","first-page":"e11448","DOI":"10.1371\/journal.pone.0011448","volume":"5","author":"M Epeldegui","year":"2010","unstructured":"Epeldegui M, Thapa DR, De la Cruz J, Kitchen S, Zack JA, Martinez-Maza O (2010) CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes. PLoS ONE 5(7):e11448","journal-title":"PLoS ONE"},{"key":"5959_CR34","doi-asserted-by":"crossref","unstructured":"Doyon-Lalibert\u00e9 K, Aranguren M, Poudrier J, Roger M, Marginal Zone B-C (2022) Populations and their Regulatory potential in the context of HIV and other chronic inflammatory conditions. Int J Mol Sci ; 23(6)","DOI":"10.3390\/ijms23063372"},{"key":"5959_CR35","doi-asserted-by":"crossref","unstructured":"Akbay B, Germini D, Bissenbaev AK, Musinova YR, Sheval EV, Vassetzky Y et al (2021) HIV-1 Tat activates Akt\/mTORC1 pathway and AICDA expression by downregulating its transcriptional inhibitors in B cells. Int J Mol Sci ; 22(4)","DOI":"10.3390\/ijms22041588"},{"issue":"7","key":"5959_CR36","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.4049\/jimmunol.176.7.3931","volume":"176","author":"B He","year":"2006","unstructured":"He B, Qiao X, Klasse PJ, Chiu A, Chadburn A, Knowles DM et al (2006) HIV-1 envelope triggers polyclonal ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J Immunol 176(7):3931\u20133941","journal-title":"J Immunol"},{"key":"5959_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ceb.2017.10.002","volume":"51","author":"E Schweighoffer","year":"2018","unstructured":"Schweighoffer E, Tybulewicz VL (2018) Signalling for B cell survival. Curr Opin Cell Biol 51:8\u201314","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"5959_CR38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.coi.2004.01.007","volume":"16","author":"A Patke","year":"2004","unstructured":"Patke A, Mecklenbr\u00e4uker I, Tarakhovsky A (2004) Survival signaling in resting B cells. Curr Opin Immunol 16(2):251\u2013255","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"5959_CR39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.semcancer.2011.09.009","volume":"21","author":"A Agathangelidis","year":"2011","unstructured":"Agathangelidis A, Hadzidimitriou A, Rosenquist R, Stamatopoulos K (2011) Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: implications for the origin and selection of the malignant cells. Semin Cancer Biol 21(5):299\u2013307","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"5959_CR40","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1038\/bcj.2017.43","volume":"7","author":"Y Kusano","year":"2017","unstructured":"Kusano Y, Yokoyama M, Terui Y, Nishimura N, Mishima Y, Ueda K et al (2017) Low absolute peripheral blood CD4\u2009+\u2009T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma. Blood Cancer J 7(5):e561","journal-title":"Blood Cancer J"},{"issue":"3","key":"5959_CR41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/1055-9965.EPI-16-0595","volume":"26","author":"X Han","year":"2017","unstructured":"Han X, Jemal A, Hulland E, Simard EP, Nastoupil L, Ward E et al (2017) HIV Infection and Survival of Lymphoma Patients in the era of highly active antiretroviral therapy. Cancer Epidemiol Biomarkers Prev 26(3):303\u2013311","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"5959_CR42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12981-023-00554-8","volume":"20","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Wang X, Lin X, Wang J, Yan X, Wen Y (2023) Sustained response following BTK inhibitors based treatment in HIV-related primary central nervous system lymphoma: case report. AIDS Res Ther 20(1):63","journal-title":"AIDS Res Ther"},{"issue":"6","key":"5959_CR43","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.21037\/tcr-22-1375","volume":"11","author":"R Zhang","year":"2022","unstructured":"Zhang R, Sun J (2022) A case report of acquired immunodeficiency syndrome (AIDS)-related refractory Burkitt lymphoma got complete remission by multidisciplinary and multi-target combined therapy. Transl Cancer Res 11(6):1806\u20131812","journal-title":"Transl Cancer Res"},{"issue":"3","key":"5959_CR44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrc.2017.121","volume":"18","author":"JA Burger","year":"2018","unstructured":"Burger JA, Wiestner A (2018) Targeting B cell receptor signalling in cancer: preclinical and clinical advances. Nat Rev Cancer 18(3):148\u2013167","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"5959_CR45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.semcancer.2013.07.006","volume":"23","author":"LA Sutton","year":"2013","unstructured":"Sutton LA, Agathangelidis A, Belessi C, Darzentas N, Davi F, Ghia P et al (2013) Antigen selection in B-cell lymphomas\u2013tracing the evidence. Semin Cancer Biol 23(6):399\u2013409","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"5959_CR46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaci.2008.04.034","volume":"122","author":"S Moir","year":"2008","unstructured":"Moir S, Fauci AS (2008) Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol 122(1):12\u201319 quiz 20\u2009\u2013\u200911","journal-title":"J Allergy Clin Immunol"},{"issue":"5128","key":"5959_CR47","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1126\/science.7690497","volume":"261","author":"L Berberian","year":"1993","unstructured":"Berberian L, Goodglick L, Kipps TJ, Braun J (1993) Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261(5128):1588\u20131591","journal-title":"Science"},{"issue":"22","key":"5959_CR48","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.vaccine.2015.04.008","volume":"33","author":"Z Hu","year":"2015","unstructured":"Hu Z, Luo Z, Wan Z, Wu H, Li W, Zhang T et al (2015) HIV-associated memory B cell perturbations. Vaccine 33(22):2524\u20132529","journal-title":"Vaccine"},{"issue":"41","key":"5959_CR49","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1073\/pnas.0506857102","volume":"102","author":"M Popovic","year":"2005","unstructured":"Popovic M, Tenner-Racz K, Pelser C, Stellbrink HJ, van Lunzen J, Lewis G et al (2005) Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci U S A 102(41):14807\u201314812","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5959_CR50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-4690-10-92","volume":"10","author":"S Curreli","year":"2013","unstructured":"Curreli S, Krishnan S, Reitz M, Lunardi-Iskandar Y, Lafferty MK, Garzino-Demo A et al (2013) B cell lymphoma in HIV transgenic mice. Retrovirology 10:92","journal-title":"Retrovirology"},{"issue":"13","key":"5959_CR51","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood.2020006784","volume":"138","author":"W Xu","year":"2021","unstructured":"Xu W, Berning P, Lenz G (2021) Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma. Blood 138(13):1110\u20131119","journal-title":"Blood"},{"issue":"1","key":"5959_CR52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","volume":"15","author":"LM Thorpe","year":"2015","unstructured":"Thorpe LM, Yuzugullu H, Zhao JJ (2015) PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer 15(1):7\u201324","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5959_CR53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-018-0803-3","volume":"17","author":"N Haddadi","year":"2018","unstructured":"Haddadi N, Lin Y, Travis G, Simpson AM, Nassif NT, McGowan EM (2018) PTEN\/PTENP1: \u2018Regulating the regulator of RTK-dependent PI3K\/Akt signalling\u2019, new targets for cancer therapy. Mol Cancer 17(1):37","journal-title":"Mol Cancer"},{"issue":"46","key":"5959_CR54","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1073\/pnas.1514748112","volume":"112","author":"R Dolcetti","year":"2015","unstructured":"Dolcetti R, Giagulli C, He W, Selleri M, Caccuri F, Eyzaguirre LM et al (2015) Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis. Proc Natl Acad Sci U S A 112(46):14331\u201314336","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5959_CR55","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1038\/s41598-017-06848-y","volume":"7","author":"C Giagulli","year":"2017","unstructured":"Giagulli C, D\u2019Ursi P, He W, Zorzan S, Caccuri F, Varney K et al (2017) A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17. Sci Rep 7(1):6555","journal-title":"Sci Rep"},{"issue":"4","key":"5959_CR56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ncb1236","volume":"7","author":"Z Li","year":"2005","unstructured":"Li Z, Dong X, Wang Z, Liu W, Deng N, Ding Y et al (2005) Regulation of PTEN by rho small GTPases. Nat Cell Biol 7(4):399\u2013404","journal-title":"Nat Cell Biol"},{"issue":"27","key":"5959_CR57","doi-asserted-by":"crossref","first-page":"e2122050119","DOI":"10.1073\/pnas.2122050119","volume":"119","author":"F Caccuri","year":"2022","unstructured":"Caccuri F, Messali S, Zani A, Campisi G, Giovanetti M, Zanussi S et al (2022) HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide. Proc Natl Acad Sci U S A 119(27):e2122050119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"5959_CR58","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jmb.2011.03.055","volume":"410","author":"X Zhu","year":"2011","unstructured":"Zhu X, Zhou F, Qin D, Zeng Y, Lv Z, Yao S et al (2011) Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi\u2019s-sarcoma-associated herpesvirus: role of Ras\/c-Raf\/MEK1\/2, PI3K\/AKT, and NF-\u03baB signaling pathways. J Mol Biol 410(5):1035\u20131051","journal-title":"J Mol Biol"},{"issue":"3","key":"5959_CR59","doi-asserted-by":"crossref","first-page":"e17831","DOI":"10.1371\/journal.pone.0017831","volume":"6","author":"C Giagulli","year":"2011","unstructured":"Giagulli C, Marsico S, Magiera AK, Bruno R, Caccuri F, Barone I et al (2011) Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS ONE 6(3):e17831","journal-title":"PLoS ONE"},{"issue":"2","key":"5959_CR60","doi-asserted-by":"crossref","first-page":"e0170771","DOI":"10.1371\/journal.pone.0170771","volume":"12","author":"SH Browne","year":"2017","unstructured":"Browne SH, Diaz-Perez JA, Preziosi M, King CC, Jones GA, Jain S et al (2017) mTOR activity in AIDS-related diffuse large B-cell lymphoma. PLoS ONE 12(2):e0170771","journal-title":"PLoS ONE"},{"key":"5959_CR61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.redox.2017.11.024","volume":"15","author":"R El-Amine","year":"2018","unstructured":"El-Amine R, Germini D, Zakharova VV, Tsfasman T, Sheval EV, Louzada RAN et al (2018) HIV-1 Tat protein induces DNA damage in human peripheral blood B-lymphocytes via mitochondrial ROS production. Redox Biol 15:97\u2013108","journal-title":"Redox Biol"},{"issue":"1","key":"5959_CR62","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1038\/s41598-018-22544-x","volume":"8","author":"K Vanshylla","year":"2018","unstructured":"Vanshylla K, Bartsch C, Hitzing C, Kr\u00fcmpelmann L, Wienands J, Engels N (2018) Grb2 and GRAP connect the B cell antigen receptor to Erk MAP kinase activation in human B cells. Sci Rep 8(1):4244","journal-title":"Sci Rep"},{"issue":"11","key":"5959_CR63","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ni.2116","volume":"12","author":"A Chaturvedi","year":"2011","unstructured":"Chaturvedi A, Martz R, Dorward D, Waisberg M, Pierce SK (2011) Endocytosed BCRs sequentially regulate MAPK and akt signaling pathways from intracellular compartments. Nat Immunol 12(11):1119\u20131126","journal-title":"Nat Immunol"},{"issue":"3","key":"5959_CR64","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3324\/haematol.2018.196931","volume":"104","author":"N Gim\u00e9nez","year":"2019","unstructured":"Gim\u00e9nez N, Mart\u00ednez-Trillos A, Montraveta A, Lopez-Guerra M, Rosich L, Nadeu F et al (2019) Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia. Haematologica 104(3):576\u2013586","journal-title":"Haematologica"},{"issue":"7","key":"5959_CR65","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/cdd.2012.1","volume":"19","author":"MW Gramling","year":"2012","unstructured":"Gramling MW, Eischen CM (2012) Suppression of Ras\/Mapk pathway signaling inhibits myc-induced lymphomagenesis. Cell Death Differ 19(7):1220\u20131227","journal-title":"Cell Death Differ"},{"issue":"1","key":"5959_CR66","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1182\/blood.V81.1.166.bloodjournal811166","volume":"81","author":"P Ballerini","year":"1993","unstructured":"Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM et al (1993) Multiple genetic lesions in acquired immunodeficiency syndrome-related non-hodgkin\u2019s lymphoma. Blood 81(1):166\u2013176","journal-title":"Blood"},{"issue":"1","key":"5959_CR67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2643-3230.BCD-20-0051","volume":"1","author":"Z Liu","year":"2020","unstructured":"Liu Z, Filip I, Gomez K, Engelbrecht D, Meer S, Lalloo PN et al (2020) Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway. Blood Cancer Discov 1(1):112\u2013125","journal-title":"Blood Cancer Discov"},{"issue":"11","key":"5959_CR68","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.186.11.1809","volume":"186","author":"M Colonna","year":"1997","unstructured":"Colonna M, Navarro F, Bell\u00f3n T, Llano M, Garc\u00eda P, Samaridis J et al (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186(11):1809\u20131818","journal-title":"J Exp Med"},{"issue":"5","key":"5959_CR69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.it.2009.02.003","volume":"30","author":"GJ Clark","year":"2009","unstructured":"Clark GJ, Ju X, Tate C, Hart DN (2009) The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol 30(5):209\u2013217","journal-title":"Trends Immunol"},{"issue":"8","key":"5959_CR70","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20072683","volume":"205","author":"S Moir","year":"2008","unstructured":"Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O\u2019Shea MA et al (2008) Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205(8):1797\u20131805","journal-title":"J Exp Med"},{"issue":"22","key":"5959_CR71","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1182\/blood-2010-09-310318","volume":"117","author":"R Silva","year":"2011","unstructured":"Silva R, Moir S, Kardava L, Debell K, Simhadri VR, Ferrando-Martinez S et al (2011) CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection. Blood 117(22):5870\u20135880","journal-title":"Blood"},{"issue":"8","key":"5959_CR72","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1084\/jem.20011435","volume":"195","author":"EU Rudge","year":"2002","unstructured":"Rudge EU, Cutler AJ, Pritchard NR, Smith KG (2002) Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and fc gamma RII-mediated B cell suppression. J Exp Med 195(8):1079\u20131085","journal-title":"J Exp Med"},{"issue":"10","key":"5959_CR73","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ajh.22119","volume":"86","author":"CS Rabkin","year":"2011","unstructured":"Rabkin CS, Engels EA, Landgren O, Schuurman R, Camargo MC, Ruth P et al (2011) Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-hodgkin lymphoma. Am J Hematol 86(10):875\u2013878","journal-title":"Am J Hematol"},{"issue":"11","key":"5959_CR74","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","volume":"378","author":"R Yarchoan","year":"2018","unstructured":"Yarchoan R, Uldrick TS (2018) HIV-Associated cancers and related diseases. N Engl J Med 378(11):1029\u20131041","journal-title":"N Engl J Med"},{"issue":"20","key":"5959_CR75","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1182\/blood-2014-11-599951","volume":"125","author":"A Arvey","year":"2015","unstructured":"Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F et al (2015) The tumor virus landscape of AIDS-related lymphomas. Blood 125(20):e14\u201322","journal-title":"Blood"},{"issue":"1","key":"5959_CR76","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/emm.2014.82","volume":"47","author":"CY Ok","year":"2015","unstructured":"Ok CY, Li L, Young KH (2015) EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management. Exp Mol Med 47(1):e132","journal-title":"Exp Mol Med"},{"issue":"2","key":"5959_CR77","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/cyto.b.21589","volume":"94","author":"EM Wohlford","year":"2018","unstructured":"Wohlford EM, Baresel PC, Wilmore JR, Mortelliti AJ, Coleman CB, Rochford R (2018) Changes in Tonsil B Cell phenotypes and EBV receptor expression in children under 5-Years-old. Cytometry B Clin Cytom 94(2):291\u2013301","journal-title":"Cytometry B Clin Cytom"},{"key":"5959_CR78","doi-asserted-by":"crossref","unstructured":"Whitehurst CB, Rizk M, Teklezghi A, Spagnuolo RA, Pagano JS, Wahl A (2022) HIV co-infection augments EBV-induced tumorigenesis in vivo. Front Virol ; 2","DOI":"10.3389\/fviro.2022.861628"},{"key":"5959_CR79","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3389\/fonc.2020.01723","volume":"10","author":"P Shindiapina","year":"2020","unstructured":"Shindiapina P, Ahmed EH, Mozhenkova A, Abebe T, Baiocchi RA (2020) Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive individuals. Front Oncol 10:1723","journal-title":"Front Oncol"},{"issue":"Pt 7","key":"5959_CR80","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1099\/vir.0.2008\/001461-0","volume":"89","author":"LJ Anderson","year":"2008","unstructured":"Anderson LJ, Longnecker R (2008) EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK\/MAPK pathway. J Gen Virol 89(Pt 7):1563\u20131568","journal-title":"J Gen Virol"},{"issue":"3","key":"5959_CR81","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","volume":"9","author":"RG Caldwell","year":"1998","unstructured":"Caldwell RG, Wilson JB, Anderson SJ, Longnecker R (1998) Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9(3):405\u2013411","journal-title":"Immunity"},{"issue":"42","key":"5959_CR82","doi-asserted-by":"crossref","first-page":"26318","DOI":"10.1073\/pnas.2007946117","volume":"117","author":"K Fish","year":"2020","unstructured":"Fish K, Comoglio F, Shaffer AL 3rd, Ji Y, Pan KT, Scheich S et al (2020) Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A. Proc Natl Acad Sci U S A 117(42):26318\u201326327","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"37","key":"5959_CR83","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1073\/pnas.1514484112","volume":"112","author":"T Minamitani","year":"2015","unstructured":"Minamitani T, Yasui T, Ma Y, Zhou H, Okuzaki D, Tsai CY et al (2015) Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A. Proc Natl Acad Sci U S A 112(37):11612\u201311617","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5959_CR84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/viro.1997.8901","volume":"240","author":"ML Roberts","year":"1998","unstructured":"Roberts ML, Cooper NR (1998) Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 240(1):93\u201399","journal-title":"Virology"},{"issue":"23","key":"5959_CR85","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1042\/BCJ20220417","volume":"479","author":"S Khasnis","year":"2022","unstructured":"Khasnis S, Veenstra H, McClellan MJ, Ojeniyi O, Wood CD, West MJ (2022) Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens. Biochem J 479(23):2395\u20132417","journal-title":"Biochem J"},{"issue":"18","key":"5959_CR86","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","volume":"332","author":"E Cesarman","year":"1995","unstructured":"Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332(18):1186\u20131191","journal-title":"N Engl J Med"},{"issue":"4","key":"5959_CR87","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hon.2372","volume":"35","author":"MA El-Fattah","year":"2017","unstructured":"El-Fattah MA (2017) Clinical characteristics and survival outcome of primary effusion lymphoma: a review of 105 patients. Hematol Oncol 35(4):878\u2013883","journal-title":"Hematol Oncol"},{"issue":"5","key":"5959_CR88","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1634\/theoncologist.12-5-569","volume":"12","author":"YB Chen","year":"2007","unstructured":"Chen YB, Rahemtullah A, Hochberg E (2007) Primary effusion lymphoma. Oncologist 12(5):569\u2013576","journal-title":"Oncologist"},{"issue":"19","key":"5959_CR89","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1128\/JVI.00797-16","volume":"90","author":"Q Yan","year":"2016","unstructured":"Yan Q, Shen C, Qin J, Li W, Hu M, Lu H et al (2016) HIV-1 Vpr inhibits Kaposi\u2019s Sarcoma-Associated Herpesvirus Lytic replication by inducing MicroRNA mir-942-5p and activating NF-\u03baB signaling. J Virol 90(19):8739\u20138753","journal-title":"J Virol"},{"issue":"14","key":"5959_CR90","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1128\/JVI.00839-15","volume":"89","author":"L Steinbruck","year":"2015","unstructured":"Steinbruck L, Gustems M, Medele S, Schulz TF, Lutter D, Hammerschmidt W (2015) K1 and K15 of Kaposi\u2019s Sarcoma-Associated Herpesvirus are partial functional homologues of latent membrane protein 2A of Epstein-Barr Virus. J Virol 89(14):7248\u20137261","journal-title":"J Virol"},{"issue":"1","key":"5959_CR91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.192.1.11","volume":"192","author":"BS Lee","year":"2000","unstructured":"Lee BS, Alvarez X, Ishido S, Lackner AA, Jung JU (2000) Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi\u2019s sarcoma-associated herpesvirus K1. J Exp Med 192(1):11\u201321","journal-title":"J Exp Med"},{"issue":"Pt 18","key":"5959_CR92","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1242\/jcs.00691","volume":"116","author":"N Field","year":"2003","unstructured":"Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C et al (2003) KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci 116(Pt 18):3721\u20133728","journal-title":"J Cell Sci"},{"issue":"7","key":"5959_CR93","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1182\/blood.V96.7.2537.h8002537_2537_2542","volume":"96","author":"SA Keller","year":"2000","unstructured":"Keller SA, Schattner EJ, Cesarman E (2000) Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96(7):2537\u20132542","journal-title":"Blood"},{"issue":"18","key":"5959_CR94","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/1078-0432.CCR-12-3510","volume":"19","author":"R Gopalakrishnan","year":"2013","unstructured":"Gopalakrishnan R, Matta H, Chaudhary PM (2013) A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-\u03baB. Clin Cancer Res 19(18):5016\u20135026","journal-title":"Clin Cancer Res"},{"issue":"6","key":"5959_CR95","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood-2010-06-275818","volume":"117","author":"F Marcucci","year":"2011","unstructured":"Marcucci F, Mele A (2011) Hepatitis viruses and non-hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 117(6):1792\u20131798","journal-title":"Blood"},{"issue":"2","key":"5959_CR96","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","volume":"347","author":"O Hermine","year":"2002","unstructured":"Hermine O, Lefr\u00e8re F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V et al (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347(2):89\u201394","journal-title":"N Engl J Med"},{"issue":"23","key":"5959_CR97","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1182\/blood-2010-05-283358","volume":"116","author":"Y Kasama","year":"2010","unstructured":"Kasama Y, Sekiguchi S, Saito M, Tanaka K, Satoh M, Kuwahara K et al (2010) Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo. Blood 116(23):4926\u20134933","journal-title":"Blood"},{"issue":"1","key":"5959_CR98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/M16-0240","volume":"166","author":"Q Wang","year":"2017","unstructured":"Wang Q, De Luca A, Smith C, Zangerle R, Sambatakou H, Bonnet F et al (2017) Chronic Hepatitis B and C virus infection and risk for Non-hodgkin Lymphoma in HIV-Infected patients: a Cohort Study. Ann Intern Med 166(1):9\u201317","journal-title":"Ann Intern Med"},{"issue":"4","key":"5959_CR99","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/QAD.0000000000002461","volume":"34","author":"C Besson","year":"2020","unstructured":"Besson C, Noel N, Lancar R, Prevot S, Algarte-Genin M, Rosenthal E et al (2020) Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV. Aids 34(4):599\u2013608","journal-title":"Aids"},{"issue":"5","key":"5959_CR100","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.4049\/jimmunol.1000879","volume":"185","author":"JM Sugalski","year":"2010","unstructured":"Sugalski JM, Rodriguez B, Moir S, Anthony DD (2010) Peripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chronic hepatitis C virus infection. J Immunol 185(5):3019\u20133027","journal-title":"J Immunol"},{"issue":"5390","key":"5959_CR101","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R et al (1998) Binding of hepatitis C virus to CD81. Science 282(5390):938\u2013941","journal-title":"Science"},{"issue":"2","key":"5959_CR102","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2249.2002.01844.x","volume":"128","author":"E Zuckerman","year":"2002","unstructured":"Zuckerman E, Slobodin G, Kessel A, Sabo E, Yeshurun D, Halas K et al (2002) Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol 128(2):353\u2013358","journal-title":"Clin Exp Immunol"},{"key":"5959_CR103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.iy.13.040195.001015","volume":"13","author":"DT Fearon","year":"1995","unstructured":"Fearon DT, Carter RH (1995) The CD19\/CR2\/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 13:127\u2013149","journal-title":"Annu Rev Immunol"},{"issue":"5053","key":"5959_CR104","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1373518","volume":"256","author":"RH Carter","year":"1992","unstructured":"Carter RH, Fearon DT (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256(5053):105\u2013107","journal-title":"Science"},{"issue":"23","key":"5959_CR105","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1038\/onc.2015.364","volume":"35","author":"B Dai","year":"2016","unstructured":"Dai B, Chen AY, Corkum CP, Peroutka RJ, Landon A, Houng S et al (2016) Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders. Oncogene 35(23):2979\u20132990","journal-title":"Oncogene"},{"issue":"12","key":"5959_CR106","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/jmv.21890","volume":"82","author":"Y Shimozuma","year":"2010","unstructured":"Shimozuma Y, Ito T, Inokuchi M, Uchikoshi M, Miyashita M, Nozawa H et al (2010) Reactivation of Epstein-Barr virus in B cells of patients with chronic hepatitis C. J Med Virol 82(12):2064\u20132072","journal-title":"J Med Virol"},{"issue":"22","key":"5959_CR107","doi-asserted-by":"crossref","first-page":"13993","DOI":"10.1128\/JVI.79.22.13993-14003.2005","volume":"79","author":"GK Hong","year":"2005","unstructured":"Hong GK, Gulley ML, Feng WH, Delecluse HJ, Holley-Guthrie E, Kenney SC (2005) Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. J Virol 79(22):13993\u201314003","journal-title":"J Virol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05959-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05959-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05959-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:08:26Z","timestamp":1735866506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05959-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":107,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5959"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05959-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}